Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV

The information in the brief version is excerpted directly from the full-text guidelines. The brief version is a compilation of the tables and boxed recommendations.

  •   Table of Contents

Download Guidelines

Appendix B: Panel Roster and Financial Disclosures

Pharmacology

Last Updated: August 1, 2019; Last Reviewed: August 1, 2019

Pharmacology
Member Financial Disclosure
Company Relationship
Dooley, Kelly Johns Hopkins University School of Medicine None N/A
George, Jomy  National Institutes of Health None N/A
Kuriakose, Safia National Institutes of Health None N/A
Pau, Alice* National Institutes of Health
None N/A
Peloquin, Charles University of Florida None N/A
Pham, Paul Johns Hopkins University, School of Medicine & Westview Urgent Care Medi Center None N/A

* Group lead

Note: Members were asked to disclose all relationships from 12 months prior to the updated date. The period of reporting was from August 1, 2018, through August 1, 2019.

Download Guidelines